Back

Belite Bio to present tinlarebant data at Euretina 2026 meetings

Verifying
  • Belite Bio will present company and tinlarebant data at Euretina meetings in Vienna.
  • September 30 and October 4, 2026, are the scheduled presentation dates.
  • Tinlarebant’s DRAGON trial met its primary endpoint, according to Belite Bio.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.